Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teppei Sakoda

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Blood Advances|August 31, 2022
Human acute leukemia uses branched-chain amino acid catabolism to maintain stemness through regulating PRC2 functionYoshikane Kikushige, Toshihiro Miyamoto, Yu Kochi, et al.
International Journal of Hematology|October 8, 2025
Burkitt in disguise: clonal transformation of incidentally detected gallbladder diffuse large B-cell lymphoma in a liver transplant recipientKohta Miyawaki, Hidetaka Nakagaki, Yasuo Mori, et al.
International Journal of Hematology|January 3, 2026
Safety and effectiveness of lisocabtagene maraleucel following PD-1 blockade in relapsed or refractory PMBCLKohei Yamaguchi, Takuji Yamauchi, Seiya Hirakawa, et al.
International Journal of Hematology|August 28, 2021
Granulocyte collection by polymorphonuclear cell-targeting apheresis with medium-molecular-weight hydroxyethyl starchTomoko Henzan, Takuji Yamauchi, Ikumi Yamanaka, et al.
Blood Advances|January 1, 2024
Thrombospondin-1 is an endogenous substrate of cereblon responsible for immunomodulatory drug-induced thromboembolismKiwamu Hatakeyama, Yoshikane Kikushige, Daisuke Ishihara, et al.
Blood|November 5, 2025
Guanine nucleotides drive ribosome biogenesis and glycolytic reprogramming in acute myeloid leukemia stem cellsGentaro Kawano, Riichiro Ikeda, Daisuke Ishihara, et al.
International Journal of Hematology|October 31, 2025
Engraftment syndrome after PD-1 blockade in classical Hodgkin lymphoma treated by autologous stem cell transplantationHuiyeon Choi, Takuji Yamauchi, Yasuo Mori, et al.
International Journal of Hematology|July 18, 2021
Optimization of lymphapheresis for manufacturing autologous CAR-T cellsIkumi Yamanaka, Takuji Yamauchi, Tomoko Henzan, et al.
Cancer Science|December 27, 2024
TIM-3 marks measurable residual leukemic stem cells responsible for relapse after allogeneic stem cell transplantationTeppei Sakoda, Yoshikane Kikushige, Hidetoshi Irifune, et al.
Blood Cell Therapy|September 10, 2025
The effective and safe administration of Epcoritamab in relapsed CD19-CD5+ DLBCL following CAR-T therapyTakashi Shimakawa, Noriaki Kawano, Yuichiro Semba, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Blood Advances|August 31, 2022
Human acute leukemia uses branched-chain amino acid catabolism to maintain stemness through regulating PRC2 functionYoshikane Kikushige, Toshihiro Miyamoto, Yu Kochi, et al.
International Journal of Hematology|October 8, 2025
Burkitt in disguise: clonal transformation of incidentally detected gallbladder diffuse large B-cell lymphoma in a liver transplant recipientKohta Miyawaki, Hidetaka Nakagaki, Yasuo Mori, et al.
International Journal of Hematology|January 3, 2026
Safety and effectiveness of lisocabtagene maraleucel following PD-1 blockade in relapsed or refractory PMBCLKohei Yamaguchi, Takuji Yamauchi, Seiya Hirakawa, et al.
International Journal of Hematology|August 28, 2021
Granulocyte collection by polymorphonuclear cell-targeting apheresis with medium-molecular-weight hydroxyethyl starchTomoko Henzan, Takuji Yamauchi, Ikumi Yamanaka, et al.
Blood Advances|January 1, 2024
Thrombospondin-1 is an endogenous substrate of cereblon responsible for immunomodulatory drug-induced thromboembolismKiwamu Hatakeyama, Yoshikane Kikushige, Daisuke Ishihara, et al.
Blood|November 5, 2025
Guanine nucleotides drive ribosome biogenesis and glycolytic reprogramming in acute myeloid leukemia stem cellsGentaro Kawano, Riichiro Ikeda, Daisuke Ishihara, et al.
International Journal of Hematology|October 31, 2025
Engraftment syndrome after PD-1 blockade in classical Hodgkin lymphoma treated by autologous stem cell transplantationHuiyeon Choi, Takuji Yamauchi, Yasuo Mori, et al.
International Journal of Hematology|July 18, 2021
Optimization of lymphapheresis for manufacturing autologous CAR-T cellsIkumi Yamanaka, Takuji Yamauchi, Tomoko Henzan, et al.
Cancer Science|December 27, 2024
TIM-3 marks measurable residual leukemic stem cells responsible for relapse after allogeneic stem cell transplantationTeppei Sakoda, Yoshikane Kikushige, Hidetoshi Irifune, et al.
Blood Cell Therapy|September 10, 2025
The effective and safe administration of Epcoritamab in relapsed CD19-CD5+ DLBCL following CAR-T therapyTakashi Shimakawa, Noriaki Kawano, Yuichiro Semba, et al.
Pageof 2